Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Mammalia
Entry Details
ID
304
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P07589 (Created: 1988-04-01 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name
FINC_BOVIN
Protein Name
Fibronectin
Gene
FN1
Organism Scientific
Bos taurus
Organism Common
Bovine
Lineage
Eukaryota
Metazoa
Chordata
Craniata
Vertebrata
Euteleostomi
Mammalia
Eutheria
Laurasiatheria
Cetartiodactyla
Ruminantia
Pecora
Bovidae
Bovinae
Bos
Protein Length [aa]
2478
Protein Mass [Da]
272154
Features
Type
Description
Status
Start
End
signal peptide
by similarity
1
32
chain
Fibronectin
33
2478
disulfide bond
by similarity
53
79
disulfide bond
by similarity
77
88
disulfide bond
by similarity
98
126
disulfide bond
by similarity
124
136
disulfide bond
by similarity
142
170
disulfide bond
by similarity
168
180
disulfide bond
by similarity
187
216
disulfide bond
by similarity
214
226
disulfide bond
by similarity
232
261
disulfide bond
by similarity
259
271
disulfide bond
by similarity
309
336
disulfide bond
by similarity
334
343
disulfide bond
by similarity
361
387
disulfide bond
by similarity
375
402
disulfide bond
by similarity
421
447
disulfide bond
by similarity
435
462
disulfide bond
by similarity
471
499
disulfide bond
by similarity
497
509
disulfide bond
by similarity
519
546
disulfide bond
by similarity
544
556
disulfide bond
by similarity
562
590
disulfide bond
by similarity
588
600
disulfide bond
by similarity
2298
2327
disulfide bond
by similarity
2325
2337
disulfide bond
by similarity
2343
2370
disulfide bond
by similarity
2368
2380
disulfide bond
by similarity
2387
2413
disulfide bond
by similarity
2411
2422
disulfide bond
Interchain (with C-2462)
by similarity
2459
2459
disulfide bond
Interchain (with C-2458)
by similarity
2463
2463
domain
Fibronectin type-I 1
51
91
domain
Fibronectin type-I 2
96
139
domain
Fibronectin type-I 3
140
183
domain
Fibronectin type-I 4
185
229
domain
Fibronectin type-I 5
230
274
domain
Fibronectin type-I 6
307
344
domain
Fibronectin type-II 1
356
404
domain
Fibronectin type-II 2
416
464
domain
Fibronectin type-I 7
469
517
domain
Fibronectin type-I 8
517
559
domain
Fibronectin type-I 9
560
603
domain
Fibronectin type-III 1
608
700
domain
Fibronectin type-III 2
721
810
domain
Fibronectin type-III 3
812
899
domain
Fibronectin type-III 4
907
996
domain
Fibronectin type-III 5
997
1085
domain
Fibronectin type-III 6
1093
1173
domain
Fibronectin type-III 7
1174
1266
domain
Fibronectin type-III 8; extra domain 1
1267
1357
domain
Fibronectin type-III 9
1358
1448
domain
Fibronectin type-III 10
1449
1538
domain
Fibronectin type-III 11
1539
1628
domain
Fibronectin type-III 12
1633
1722
domain
Fibronectin type-III 13; extra domain 2
1723
1812
domain
Fibronectin type-III 14
1815
1902
domain
Fibronectin type-III 15
1905
1993
domain
Fibronectin type-III 16
1994
2083
domain
Fibronectin type-III 17
2192
2282
domain
Fibronectin type-I 10
2296
2340
domain
Fibronectin type-I 11
2341
2383
domain
Fibronectin type-I 12
2385
2428
region of interest
Fibrin- and heparin-binding 1
53
273
region of interest
Collagen-binding
309
609
region of interest
Cell-attachment
1359
1632
region of interest
Heparin-binding 2
1813
2083
region of interest
Connecting strand 3 (CS-3) (V region)
2084
2203
region of interest
Fibrin-binding 2
2298
2429
modified residue
Pyrrolidone carboxylic acid
by similarity
33
33
modified residue
Sulfotyrosine
potential
877
877
modified residue
Sulfotyrosine
potential
882
882
modified residue
Phosphoserine
by similarity
905
905
modified residue
Sulfotyrosine
potential
2394
2394
modified residue
Phosphoserine
by similarity
2476
2476
glycosylation site
N-linked (GlcNAc...)
potential
431
431
glycosylation site
N-linked (GlcNAc...)
potential
529
529
glycosylation site
N-linked (GlcNAc...)
potential
543
543
glycosylation site
N-linked (GlcNAc...)
potential
878
878
glycosylation site
N-linked (GlcNAc...)
potential
1008
1008
glycosylation site
N-linked (GlcNAc...)
potential
1245
1245
glycosylation site
N-linked (GlcNAc...)
potential
1292
1292
glycosylation site
O-linked (GalNAc...)
2156
2156
glycosylation site
O-linked (GalNAc...)
2157
2157
glycosylation site
N-linked (GlcNAc...)
potential
2200
2200
short sequence motif
Cell attachment site
by similarity
1616
1618
short sequence motif
Cell attachment site
by similarity
2183
2185
DNA-binding region
908
1173
cross-link
Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)
by similarity
35
35
cross-link
Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)
by similarity
36
36
cross-link
Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)
by similarity
48
48
SP Length
32
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MLGGPGPGLLLLLAVLSLGTAVPSAGASKSRR
Sequence
MLGGPGPGLLLLLAVLSLGTAVPSAGASKSRR
Q
A
Q
Q
IVQPQSPLTVS
Q
SK
PG
CYDNGKHYQINQQWERTYLGSALVCTCYGGSRGFNCESKPEPEETCFD
KYTGNTYRVGDTYERPKDSMIWDCTCIGAGRGRISCTIANRCHEGGQSYK
IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEKCFDQAAGTSYVVGE
TWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSYRIGDTWSKK
DNRGNLLQCICTGNGRGEWKCER
H
TSLQTTSAGSGSFTDVRTAIYQPQPH
PQPPPY
GH
CVTDSGVVYSVGMQWLKTQGNKQMLCTCLGNGVSCQETAVTQ
TYGGNSNGEPCVLPFTYNGKTFYSCTTEGRQDGHLWCSTTSNYEQDQKYS
FCTDHTVLVQTRGGNSNGALCHFPFLYNNH
N
YTDCTSEGRRDNMKWCGTT
QNYDADQKFGFCPMAAHEEICTTNEGVMYRIGDQWDKQHDMGHMMRCTCV
GNGRGEWTCVAYSQLRDQCIVDGITYNV
N
DTFHKRHEEGHML
N
CTCFGQG
RGRWKCDPVDQCQDSETRTFYQIGDSWEKYLQGVRYQCYCYGRGIGEWAC
QPLQTYPDT
SGPVQVIITETPSQPNSHPIQWSAPESSHISKYILRWKPKN
SPDRWKEATIPGHLNSYTIKGLRPGVVYEGQLISVQHYGQREVTRFDFTT
TSTSPAVTSNTVTGETTPLS
PVVATSESVTEITASSFVVSWVSASDTVSG
FRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYTVNVYEISEEGEQ
NLILSTSQTT
A
PDAPPDPTVDQVDDTSIVVRWSRPRAPITGYRIVYSPSV
EGSSTELNLPETANSVTLSDLQPGVQ
Y
N
ITI
Y
AVEENQESTPVFIQQET
T
GVPR
S
D
K
VPPPRDLQFVEVTDVKITIMWTPPESPVTGYRVDVIPVNLPGE
HGQRLPVSRNTFAEVTGLSPGVTYHFKVFAVNQGRESKPLTAQQATKLDA
PTNLQFINETDTTVIVTWTPPRARIVGYRLTVGLTRGGQPKQYNVGPAAS
QYPLRNLQPGSEYAVSLVAVKGNQQSPRVTGVFTTLQPLGSIPHYNTEVT
ETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSESGSIVVSGLTPGVEY
VYTISVLRDGQERDAPIVKKVVT
PLSPPTNLHLEANPDTGVLTVSWERST
TPDITGYRITTTPTNGQQGYSLEEVVHADQSSCTFENLSPGLEY
N
VSVYT
VKDDKESVPISDTIIP
EVPQLTDLSFVDITDSSIGLRWTPL
N
SSTIIGYR
ITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISVITLINGGESAP
TTLTQQT
A
VPPPTDLRFTNVGPDTMRVTWAPPSSIELTNLLVRYSPVKNE
EDVAELSISPSDNAVVLTNLLPGTEYLVSVSSVYEQHESIPLRGRQKTAL
DSPSGIDFSDITANSFTVHWIAPRATITGYRIRHHPENMGGRPREDRVPP
SRNSITLTNLNPGTEYVVSIVALNSKEESLPLVGQQSTVSDVPRDLEVIA
ATPTSLLISWDAPAVTVRYYRITYGETGGSSPVQEFTVPGSKSTATISGL
KPGVDYTITVYAVTG
RGD
SPASSKPVSINYRT
EIDKPSQMQVTDVQDNSI
SVRWLPSSSPVTGYRVTTAPKNGPGPSKTKTVGPDQTEMTIEGLQPTVEY
VVSVYAQNQNGESQPLVQTAVT
NIDRPKGLAFTDVDVDSIKIAWESPQGQ
VSRYRVTYSSPEDGIHELFPAPDGEEETAELQGLRPGSEYTVSVVALHDD
MESQPLIGTQST
TIPAPTNLKFTQVTPTSLTAQWTAPNVQLTGYRVRVTP
KEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVV
TTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAIPANGQTPIQ
RTIRPDVRSYTITGLQPGTDYKIHLYTLNDNARSSPVVIDASTAIDAPSN
LRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEA
TITGLEPGTEYTIQVIALKNNQKSEPLIGRKKT
DELPQLVTLPHPNLHGP
EILDVPSTVQKTPFITNPGYDTGNGIQLPGTSGQQPSLGQQMIFEEHGFR
RTTPP
T
T
ATPVRHRPRPYPPNVNEEIQIGHVP
RGD
VDHHLYPHVVGLNP
N
AST
GQEALSQTTISWTPFQESSEYIISCHPVGIDEEPLQFRVPGTSASAT
LTGLTRGATYNIIVEAVKDQQRQKVREEVVTV
GNSVDQGLSQPTD
DS
CFD
PYTVSHYAIGEEWERLSDSGFKLSCQCLGFGSGHFRCDSSKWCHDNGVNY
KIGEKWDRQGENGQMMSCTCLGNGKGEFKCDPHEATCYDDGKT
Y
HVGEQW
QKEYLGAICSCTCFGGQRGWRCDNCRRPG
AEPGNEGSTAHSYNQYSQRYH
QRTNTNVN
C
PIE
C
FMPLDVQADRED
S
RE
Original
MLGGPGPGLLLLLAVLSLGTAVPSAGASKSRRQAQQIVQPQSPLTVSQSK
PGCYDNGKHYQINQQWERTYLGSALVCTCYGGSRGFNCESKPEPEETCFD
KYTGNTYRVGDTYERPKDSMIWDCTCIGAGRGRISCTIANRCHEGGQSYK
IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEKCFDQAAGTSYVVGE
TWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSYRIGDTWSKK
DNRGNLLQCICTGNGRGEWKCERHTSLQTTSAGSGSFTDVRTAIYQPQPH
PQPPPYGHCVTDSGVVYSVGMQWLKTQGNKQMLCTCLGNGVSCQETAVTQ
TYGGNSNGEPCVLPFTYNGKTFYSCTTEGRQDGHLWCSTTSNYEQDQKYS
FCTDHTVLVQTRGGNSNGALCHFPFLYNNHNYTDCTSEGRRDNMKWCGTT
QNYDADQKFGFCPMAAHEEICTTNEGVMYRIGDQWDKQHDMGHMMRCTCV
GNGRGEWTCVAYSQLRDQCIVDGITYNVNDTFHKRHEEGHMLNCTCFGQG
RGRWKCDPVDQCQDSETRTFYQIGDSWEKYLQGVRYQCYCYGRGIGEWAC
QPLQTYPDTSGPVQVIITETPSQPNSHPIQWSAPESSHISKYILRWKPKN
SPDRWKEATIPGHLNSYTIKGLRPGVVYEGQLISVQHYGQREVTRFDFTT
TSTSPAVTSNTVTGETTPLSPVVATSESVTEITASSFVVSWVSASDTVSG
FRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYTVNVYEISEEGEQ
NLILSTSQTTAPDAPPDPTVDQVDDTSIVVRWSRPRAPITGYRIVYSPSV
EGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVFIQQETT
GVPRSDKVPPPRDLQFVEVTDVKITIMWTPPESPVTGYRVDVIPVNLPGE
HGQRLPVSRNTFAEVTGLSPGVTYHFKVFAVNQGRESKPLTAQQATKLDA
PTNLQFINETDTTVIVTWTPPRARIVGYRLTVGLTRGGQPKQYNVGPAAS
QYPLRNLQPGSEYAVSLVAVKGNQQSPRVTGVFTTLQPLGSIPHYNTEVT
ETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSESGSIVVSGLTPGVEY
VYTISVLRDGQERDAPIVKKVVTPLSPPTNLHLEANPDTGVLTVSWERST
TPDITGYRITTTPTNGQQGYSLEEVVHADQSSCTFENLSPGLEYNVSVYT
VKDDKESVPISDTIIPEVPQLTDLSFVDITDSSIGLRWTPLNSSTIIGYR
ITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISVITLINGGESAP
TTLTQQTAVPPPTDLRFTNVGPDTMRVTWAPPSSIELTNLLVRYSPVKNE
EDVAELSISPSDNAVVLTNLLPGTEYLVSVSSVYEQHESIPLRGRQKTAL
DSPSGIDFSDITANSFTVHWIAPRATITGYRIRHHPENMGGRPREDRVPP
SRNSITLTNLNPGTEYVVSIVALNSKEESLPLVGQQSTVSDVPRDLEVIA
ATPTSLLISWDAPAVTVRYYRITYGETGGSSPVQEFTVPGSKSTATISGL
KPGVDYTITVYAVTGRGDSPASSKPVSINYRTEIDKPSQMQVTDVQDNSI
SVRWLPSSSPVTGYRVTTAPKNGPGPSKTKTVGPDQTEMTIEGLQPTVEY
VVSVYAQNQNGESQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQ
VSRYRVTYSSPEDGIHELFPAPDGEEETAELQGLRPGSEYTVSVVALHDD
MESQPLIGTQSTTIPAPTNLKFTQVTPTSLTAQWTAPNVQLTGYRVRVTP
KEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVV
TTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAIPANGQTPIQ
RTIRPDVRSYTITGLQPGTDYKIHLYTLNDNARSSPVVIDASTAIDAPSN
LRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEA
TITGLEPGTEYTIQVIALKNNQKSEPLIGRKKTDELPQLVTLPHPNLHGP
EILDVPSTVQKTPFITNPGYDTGNGIQLPGTSGQQPSLGQQMIFEEHGFR
RTTPPTTATPVRHRPRPYPPNVNEEIQIGHVPRGDVDHHLYPHVVGLNPN
ASTGQEALSQTTISWTPFQESSEYIISCHPVGIDEEPLQFRVPGTSASAT
LTGLTRGATYNIIVEAVKDQQRQKVREEVVTVGNSVDQGLSQPTDDSCFD
PYTVSHYAIGEEWERLSDSGFKLSCQCLGFGSGHFRCDSSKWCHDNGVNY
KIGEKWDRQGENGQMMSCTCLGNGKGEFKCDPHEATCYDDGKTYHVGEQW
QKEYLGAICSCTCFGGQRGWRCDNCRRPGAEPGNEGSTAHSYNQYSQRYH
QRTNTNVNCPIECFMPLDVQADREDSRE
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11